LI
KALA icon

Leap Investments’s KALA BIO KALA Stock Holding History

Leap Investments’s Portfolio KALA Stock Details KALA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		$199K Buy
+8
New +$227K 0.13% 298

Other funds holding KALA

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BBVA
Banco Bilbao Vizcaya Argentaria Madrid, Spain $14.3B AUM 26.23% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Leap Investments's KALA Position: Q2 2020 in Review

Leap Investments opened a new position in KALA BIO (KALA) in Q2 2020: 8 shares worth $199K. The stake represents 0.13% of the portfolio and ranks #298 among its holdings.

113 funds tracked by Wall St. Rank hold KALA as of Q2 2020.

  • Leap Investments held 8 shares of KALA BIO worth $199K as of Q2 2020.
  • KALA BIO was a new Leap Investments position in Q2 2020.
  • KALA BIO made up 0.13% of Leap Investments's portfolio in Q2 2020, its #298 holding.
  • 113 funds tracked by Wall St. Rank held KALA BIO as of Q2 2020.

Based on Leap Investments's 13F filing for Q2 2020, filed 3 Aug 2020.